Brief: Celularity Says Co And Oncternal Therapeutics Enter Into Research Collaboration To Evaluate Targeted Placental-Derived Cellular Therapies
20/09/2021 13:14
Sept 20 (Reuters) - Celularity Inc CELU.O :
* CELULARITY AND ONCTERNAL THERAPEUTICS ENTER INTO RESEARCH
COLLABORATION TO EVALUATE TARGETED PLACENTAL-DERIVED CELLULAR
THERAPIES
Source text for Eikon: ID:nGNX5fb1Cj
Further company coverage: CELU.O
Recent news on Oncternal Therapeutics
See all newsOncternal Therapeutics Inc expected to post a loss of $3.19 a share - Earnings Preview
Brief: Oncternal Therapeutics Workforce Reduction Of About 10 Employees
U.S. STOCKS ON THE MOVE-Unity Software, Viking Holdings, Adobe
U.S. STOCKS ON THE MOVE-Gold miners, silver miners, Warner Bros Discovery
Oncternal hits record low on plans to scrap studies, explore strategic alternatives;